Medical device companies operate at the intersection of healthcare, technology, and regulation. Adoption is not guaranteed by product performance alone. For devices to succeed in the real world — to be used correctly, consistently, and safely — they must be surrounded by support infrastructure that can guide patients through onboarding, answer technical questions without crossing into clinical advice, manage order and logistics inquiries at scale, and capture post-market feedback, complaints, and adverse event reports in a manner that meets FDA documentation obligations. Building this infrastructure internally is resource-intensive, difficult to scale, and carries regulatory risk if processes are inconsistently executed. Ameridial’s medical device BPO services are designed to carry this operational load — providing trained, non-clinical specialist teams, structured workflows, and AI-enhanced quality oversight that protect device programs, brand trust, and patient safety simultaneously.
Ameridial supports medical device manufacturers, DME suppliers, and digital health companies across six service areas: device customer and patient support, patient onboarding and device education, Tier 1 technical support (non-clinical), remote patient monitoring (RPM) engagement support, order management and logistics coordination, and post-market feedback and adverse event intake. For regulated complaint handling and adverse event reporting, Ameridial’s intake workflows are designed to operate in alignment with FDA 21 CFR Part 803 (Medical Device Reporting) documentation requirements — capturing complaint data accurately, routing to internal quality and regulatory teams, and supporting MDR-obligated reporting timelines. All services are delivered in HIPAA-compliant, SOC 2 Type II-audited, and PCI DSS 4.0.1-certified environments with 24/7/365 support availability.

Support device manufacturers with patient onboarding, customer support, technical helpdesk, and post-market feedback intake — operating within FDA-aligned complaint handling workflows that protect product integrity, support MDR documentation requirements, and maintain the non-clinical boundaries required for compliance.

Deliver scalable customer support, order management, and logistics coordination for durable medical equipment suppliers — managing high-volume inbound inquiries, delivery status requests, setup support, and insurance coordination workflows across CPAP, mobility, diabetes, and other DME product lines.

Support RPM platforms, connected health apps, and digital therapeutics with patient onboarding, engagement and adherence outreach, app and connectivity troubleshooting, and program participation follow-up — non-clinical BPO support that improves activation rates and sustains long-term user engagement.

Provide high-touch patient support for diabetes device companies (CGM, insulin delivery), sleep apnea and CPAP manufacturers, and specialty device brands — with agents trained on device-specific onboarding protocols, consumable reorder workflows, connectivity troubleshooting, and program adherence engagement.

Inbound and outbound customer support for device users, caregivers, and program participants — managing product enquiries, usage questions, programme enrolment, and remote monitoring support across approved channels with trained, device-aware agents.

Guided device setup, usage education, and programme orientation using manufacturer-approved scripts and materials — improving first-use confidence, reducing setup errors, and accelerating device adoption for patients and caregivers.

First-level troubleshooting, error code interpretation, connectivity support, and escalation coordination for device-related issues — resolving common hardware, software, and integration problems within non-clinical scope, with clear escalation pathways to manufacturer technical and clinical teams.

Support for order intake, fulfilment coordination, delivery status tracking, and logistics enquiries — ensuring patients and providers have accurate, timely information on device orders and replacements while reducing inbound contact volume to manufacturer operations teams.

Structured complaint intake and adverse event reporting support aligned to FDA 21 CFR Part 803 (MDR) documentation requirements — capturing device complaints, safety reports, and adverse event data accurately, routing to internal quality and regulatory teams, and supporting manufacturers' MDR-obligated reporting timelines.

Outbound patient and provider notification support for device recalls, field safety corrective actions (FSCAs), and product advisories — reaching affected device users across communication channels with manufacturer-approved messaging and documenting notification completion for regulatory records.
See how Ameridial partners with healthcare organizations to solve challenges, streamline processes, and elevate patient engagement through proven BPO strategies.
Ameridial integrates AI tools across medical device BPO workflows — monitoring every patient interaction for quality and regulatory compliance, automating routine device and order enquiries, and providing agents with real-time guidance on FDA-aligned complaint handling and technical support protocols.
MedTech companies choose Ameridial as their medical device BPO partner for the combination of regulatory-aware support design, device-trained specialist teams, FDA-aligned complaint intake workflows, and the HIPAA-compliant, AI-monitored contact centre infrastructure that high-stakes device programs require.
Ameridial aligns MedTech services to device safety standards, regulatory expectations, and real-world user needs—ensuring scalable support without clinical risk.
Ameridial’s adverse event intake workflows are designed to operate in alignment with FDA 21 CFR Part 803 (Medical Device Reporting) requirements. Trained agents follow manufacturer-approved intake scripts to capture complete complaint data, classify reportability, and route information accurately to the manufacturer’s internal quality and regulatory teams. Ameridial does not make MDR reportability determinations — that responsibility remains with the manufacturer’s regulatory team — but our structured intake and documentation processes are designed to support manufacturers’ MDR-obligated reporting timelines and MAUDE submission workflows.
Most medical device BPO programmes launch within 4–8 weeks, depending on device complexity, manufacturer-specific script and protocol development, system integration requirements, and programme scope. FDA-aligned adverse event intake programmes may require additional time for workflow validation and agent compliance training. Recall notification programmes can typically be activated on accelerated timelines given the urgency of recall events — Ameridial’s implementation team is experienced in rapid deployment for time-sensitive device safety communications.
Still have questions?
Schedule a consultation with our team.
© 2026 Ameridial Inc. – the nation’s leading healthcare contact center. All Rights Reserved.